Sara joined Eradigm in August 2023 as an Associate Consultant. With an impressive background as a Scientist in cell therapy, Sara brings a wealth of experience that will play a pivotal role in bridging the gap between research & development and innovation within the organisation.
Previouly, Sara worked as one of the very first R&D members at Mogrify, a biotech start-up at the Cambridge Science Park. During her four-year tenure, she developed expertise in pre-clinical strategy decision making regarding delivery methods such as AAVs, IVTs, and Lentivirus. She also worked across various teams (chondrocytes, ophthalmology and immunology) where her data influenced the business strategy. Sara has first-hand experience of the challenges and triumphs that come with establishing a biotech company.
In 2019, Sara graduated with a 1st class honors Biomedical Science degree from the University of Westminster, where she engaged in extensive CRISPR-related work during her undergraduate project. With her academic achievements, Sara embarked on a journey of continual growth, determined to make a difference in the world of regenerative medicine, drug discovery and beyond.
Outside of work, Sara loves reading and writing poetry. She is always hunting for open mic events where she can be inspired by other poets. Sara has a passion for teaching Arabic to children. Embracing her heritage, Sara has recently started learning how to play the Oud.
Sara is committed to excellence. She is ready to seize every opportunity and tackle challenges head-on in her role as an Associate Consultant at Eradigm.